SG11201606856SA - Modulation of cell growth and glycosylation in recombinant glycoprotein production - Google Patents

Modulation of cell growth and glycosylation in recombinant glycoprotein production

Info

Publication number
SG11201606856SA
SG11201606856SA SG11201606856SA SG11201606856SA SG11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA
Authority
SG
Singapore
Prior art keywords
glycosylation
modulation
cell growth
recombinant glycoprotein
glycoprotein production
Prior art date
Application number
SG11201606856SA
Other languages
English (en)
Inventor
Oliver Popp
Nicola Beaucamp
Georg Drabner
Stephanie Esslinger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201606856S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201606856SA publication Critical patent/SG11201606856SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201606856SA 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production SG11201606856SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14157030 2014-02-27
PCT/EP2015/053804 WO2015128314A1 (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Publications (1)

Publication Number Publication Date
SG11201606856SA true SG11201606856SA (en) 2016-09-29

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606856SA SG11201606856SA (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Country Status (20)

Country Link
US (3) US20170058309A1 (enrdf_load_stackoverflow)
EP (1) EP3110961B1 (enrdf_load_stackoverflow)
JP (2) JP6831702B2 (enrdf_load_stackoverflow)
KR (1) KR102280638B1 (enrdf_load_stackoverflow)
CN (1) CN106133146B (enrdf_load_stackoverflow)
BR (1) BR112016017660B1 (enrdf_load_stackoverflow)
CA (1) CA2937611C (enrdf_load_stackoverflow)
DK (1) DK3110961T3 (enrdf_load_stackoverflow)
ES (1) ES2769003T3 (enrdf_load_stackoverflow)
HR (1) HRP20200100T1 (enrdf_load_stackoverflow)
HU (1) HUE047575T2 (enrdf_load_stackoverflow)
LT (1) LT3110961T (enrdf_load_stackoverflow)
MX (1) MX369395B (enrdf_load_stackoverflow)
PL (1) PL3110961T3 (enrdf_load_stackoverflow)
PT (1) PT3110961T (enrdf_load_stackoverflow)
RS (1) RS59881B1 (enrdf_load_stackoverflow)
RU (1) RU2712562C2 (enrdf_load_stackoverflow)
SG (1) SG11201606856SA (enrdf_load_stackoverflow)
SI (1) SI3110961T1 (enrdf_load_stackoverflow)
WO (1) WO2015128314A1 (enrdf_load_stackoverflow)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6178330B2 (ja) 2011-11-21 2017-08-09 イノベーション・ハマー・エルエルシー ケイ酸塩系基材を使用して植物を成長させ、増強された光合成生産性で栽培し、内因性グリコピラノシル−タンパク質誘導体に対する外因性グリコピラノシドを使用することにより光安全化するための方法及びシステム、並びにその調合物、プロセス、及びシステム
MX369395B (es) * 2014-02-27 2019-11-07 Hoffmann La Roche Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante.
JP6698681B2 (ja) * 2014-12-01 2020-05-27 アムジエン・インコーポレーテツド 糖タンパク質のグリカン含量のレベルを操作するためのプロセス
JP7313150B2 (ja) 2016-04-29 2023-07-24 イノベーション・ハマー・エルエルシー グリカンコンポジット配合物で光合成生物を処理し、収穫物の品質及び量を高めるための配合物及び方法
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research ZINC SUPPLEMENTATION TO DECREASE GALACTOSYLATION OF RECOMBINANT GLYCOPROTEINS
EP3775251A1 (en) 2018-03-26 2021-02-17 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
US20210147532A1 (en) * 2018-05-24 2021-05-20 Ares Trading S.A. Method for controlling the afucosylation level of a glycoprotein composition
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
EA202191352A1 (ru) * 2018-11-13 2021-08-11 Янссен Байотек, Инк. Контроль содержания микроэлементов-металлов во время продукции антител к cd38
JP2020188737A (ja) * 2019-05-23 2020-11-26 東ソー株式会社 抗体依存性細胞傷害活性が向上した抗体の製造方法
WO2021214277A1 (en) * 2020-04-24 2021-10-28 F. Hoffmann-La Roche Ag Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
WO2025036924A1 (en) * 2023-08-16 2025-02-20 Glaxosmithkline Intellectual Property Limited Method of controlling antibody glycosylation profile

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
WO1998008934A1 (en) 1996-08-30 1998-03-05 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
EP1092037B1 (en) 1998-05-29 2005-12-28 Genentech, Inc. Cell culture process for producing glycoproteins
JP2001120262A (ja) * 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
DE60230858D1 (de) 2001-02-15 2009-03-05 Centocor Inc Chemisch definiertes medium für kultivierte säugerzellen
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
CN101052708B (zh) 2004-11-02 2012-08-29 阿雷斯贸易股份有限公司 哺乳动物细胞的无血清细胞培养基
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
US7972810B2 (en) 2005-12-08 2011-07-05 Amgen Inc. Production of glycoproteins using manganese
TR201807021T4 (tr) 2006-07-13 2018-06-21 Wyeth Llc Geliştirilmiş glikosilasyon şablonuna sahip pıhtılaşma faktörü ıx?un üretilmesi.
US8192951B2 (en) 2006-11-03 2012-06-05 Wyeth Llc Glycolysis-inhibiting substances in cell culture
RU2009132986A (ru) 2007-03-02 2011-04-10 Уайт (Us) Применение меди и глутамата в культуре клеток для производства полипептидов
WO2011019622A1 (en) * 2009-08-14 2011-02-17 Genentech, Inc. Cell culture methods to make antibodies with enhanced adcc function
WO2011095596A1 (en) * 2010-02-04 2011-08-11 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
JP5980772B2 (ja) 2010-04-26 2016-08-31 ノバルティス アーゲー 改良型細胞培養培地
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN105189735B (zh) 2011-04-29 2019-04-12 拜康研究有限公司 在培养期间减少乳酸累积的方法和生产多肽的方法
WO2013114245A1 (en) * 2012-01-30 2013-08-08 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
MX369395B (es) * 2014-02-27 2019-11-07 Hoffmann La Roche Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante.

Also Published As

Publication number Publication date
ES2769003T3 (es) 2020-06-24
EP3110961B1 (en) 2019-11-27
US20210222220A1 (en) 2021-07-22
RU2016138176A3 (enrdf_load_stackoverflow) 2018-10-29
SI3110961T1 (sl) 2020-03-31
JP2017506515A (ja) 2017-03-09
CN106133146B (zh) 2021-05-04
LT3110961T (lt) 2020-02-10
BR112016017660B1 (pt) 2022-04-19
CA2937611A1 (en) 2015-09-03
CN106133146A (zh) 2016-11-16
CA2937611C (en) 2023-01-03
RU2712562C2 (ru) 2020-01-29
PT3110961T (pt) 2020-01-29
JP6934507B2 (ja) 2021-09-15
WO2015128314A1 (en) 2015-09-03
EP3110961A1 (en) 2017-01-04
KR20160125514A (ko) 2016-10-31
HUE047575T2 (hu) 2020-04-28
MX369395B (es) 2019-11-07
JP2020054351A (ja) 2020-04-09
DK3110961T3 (da) 2020-02-03
US20240327890A1 (en) 2024-10-03
PL3110961T3 (pl) 2020-04-30
MX2016010236A (es) 2016-10-13
RU2016138176A (ru) 2018-03-29
HRP20200100T1 (hr) 2020-04-03
BR112016017660A2 (enrdf_load_stackoverflow) 2017-08-08
RS59881B1 (sr) 2020-03-31
KR102280638B1 (ko) 2021-07-22
JP6831702B2 (ja) 2021-02-17
US20170058309A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
SG11201606856SA (en) Modulation of cell growth and glycosylation in recombinant glycoprotein production
IL253248A0 (en) Natural killer cells and their uses
SG11201609118RA (en) Modified natural killer cells and uses thereof
SG10201912576PA (en) Natural killer cells and ilc3 cells and uses thereof
ZA201605308B (en) Plant growth promoting rhizobacterial strains and their uses
ZA201704595B (en) Methods of producing long acting ctp-modified growth hormone polypeptides
IL263779A (en) Protein production in plant cells
DK3242935T3 (da) O-glycansialylerede rekombinante glycoproteiner og cellelinjer til fremstilling deraf
EP2971035A4 (en) RECOMBINED POLYPEPTIDE PRODUCTION
EP3322429B8 (en) Growth promoting peptides and uses thereof
IL247776A0 (en) Methods for the production of substituted glycoproteins with adapted glycosylation
ZA201700867B (en) Modifying protein production in plants
IL250530B (en) Production of functional and fully processed factor x in a mammalian purine-secreting expression system
SI3289088T1 (sl) Odklop rasti in proizvodnja proteina
IL240639A0 (en) Formulations and methods for increased recombinant production of protein
GB2517846B (en) Improvements in and relating to loudspeakers
PL3158055T3 (pl) Ulepszone wytwarzanie rekombinowanego czynnika von Willebranda w bioreaktorze
IL258193A (en) Modified death-inducing cells with anti-pyotactic properties and their use
GB201308120D0 (en) Recombinant protein and method for its production
GB201308218D0 (en) Chlor-Alkali Process and Plant
GB2530075B (en) Improvements in and relating to eyewashing
GB201610164D0 (en) Modified natural killer cells and natural killer cell lines having increased cytoxicity
DE112015003749A5 (de) Peptid zur verwendung in der reduktion von nebenwirkungen in form von immunstimulatorischen reaktionen/effekten
GB201412354D0 (en) Improvements in and relating to loudspeakers
GB201408062D0 (en) Improvements in and relating to loudspeakers